The etiology of skeletal deficits in prepubertal down syndrome mouse models

Active Grant Awarded Last action

Award ID
F31AR087234
Recipient
Awarding agency
Obligated
$38,628

Award facts

Assistance listing
93.310 Trans-NIH Research Support
Completion date 10% complete
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
Place of performance
Indianapolis, IN 46202, USA

Award details come from USAspending.gov.

Description

Abstract
All individuals with down syndrome (DS) or trisomy 21 (TS21) present with skeletal insufficiency due to triplication of human chromosome 21 (HSA21). Skeletal insufficiency leads to an increased risk of early-onset osteoporosis and mortality-causing fractures in people with DS. The presence and severity of skeletal insufficiency in DS is sexually dimorphic, where men with DS tend to have more deficits than women with DS depending on age, skeletal site, and bone compartment. There have been no clinical trials targeting the treatment of skeletal deficits in individuals with DS, despite the clear issue, due to a lack of information regarding the SEX-specific mechanisms behind DS-associated skeletal deficits. Sexually dimorphic skeletal insufficiency in the TS21 skeleton occurs prior to puberty in both sexes and despite seemingly normal SEX hormone levels, suggesting other factors are likely contributing. There is a critical need to understand the extent of and mechanism behind sexually dimorphic DS-associated skeletal phenotypes to design treatments to improve skeletal phenotypes. The long-term goal of this research is to identify SEX-specific factors other than SEX hormone levels, such as SEX hormone receptor signaling or SEX chromosome gene interactions, to lead to targetable mechanisms to improve bone health in individuals with DS. This will be accomplished by utilizing the DP16 DS mouse model, which have shown robust sexual dimorphism in long bone phenotypes, and the four core genotypes (FCG) mouse, which uncouples SEX chromosome complement from gonadal SEX to understand their independent contributions, generating 8 types of offspring (DP16-FCG). Aim 1 will quantify the structural and mechanical properties of DP16-FCG long bones around puberty. Aim 2 will establish cellular mechanisms and growth patterns within long bones of prepubertal DP16-FCG mice. Aim 3 will measure SEX hormone signaling around puberty in biospecimens from individuals with DS and DP16-FCG offspring. Completion of these aims will assess the impact of SEX chromosome complement and gonadal SEX on whole bone to cellular skeletal phenotypes in DS mice during a targetable window of development and find the mechanism for SEX-specific bone development in DS. This work will also establish a tool for the DS research community to investigate mechanisms of sexual dimorphism in other phenotypes.

Transactions

Action Obligated Date
Amendment $0
Original award $38,628

Quick answers

Who received award F31AR087234?

F31AR087234 was awarded to Trustees Of Indiana University by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 9, 2026.

How much is award F31AR087234 worth?

$38,628 has been obligated on F31AR087234.

Which agency awarded F31AR087234?

National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) awarded F31AR087234, with funding from Office of the Director (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award